Co-Founder And Ceo
CurrentVysioneer is an oncology AI company. We aim to improve the clarity about tumor heterogeneity in cancer treatment with lesion-level data. Leveraging our FDA-cleared AI platform, we support our pharma partners to unlock lesion-level tumor characteristics to de-risk and accelerate clinical trials.